Post by Tony Crispino on Mar 27, 2014 19:37:31 GMT -8
Attached to this post is the PDF file of the Natoinal Comprehensive Cancer Network (NCCN) 2014 ￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼￼NCCN Guidelines Version 1.2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guideline®). Please see the attached file.
I guess the two big issues are how to incorporate the CHAARTED findings, and the optimal use ZA/Xgeva/Prolia. It will be interesting to see if NCCN goes with the "any mets" opinion or the "multi-mets" opinion. Most likely they will just mention both opinions and leave it to the clinician.
There have also been some noises about re-working their risk stratification system.